{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:19:05Z","timestamp":1792451945862,"version":"4.5.0"},"reference-count":244,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-023-00461-2","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T08:02:27Z","timestamp":1695888147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Hepatitis A virus infection"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-1249","authenticated-orcid":false,"given":"Pierre","family":"Van Damme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-6648","authenticated-orcid":false,"given":"Rosa M.","family":"Pint\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongdi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-6513","authenticated-orcid":false,"given":"Daniel","family":"Shouval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"461_CR1","first-page":"493","volume":"97","author":"World Health Organization.","year":"2022","unstructured":"World Health Organization. WHO position paper on hepatitis A vaccines \u2014 October 2022. Wkly Epidemiol. Rec. 97, 493\u2013512 (2022).","journal-title":"Wkly Epidemiol. Rec."},{"key":"461_CR2","unstructured":"Shouval, D. & Van Damme, P. WHO Immunological Basis for Immunization Series: Module 18: Hepatitis A, Update 2019. WHO https:\/\/apps.who.int\/iris\/handle\/10665\/326501 (2019)."},{"key":"461_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.08.034","author":"SM Lemon","year":"2017","unstructured":"Lemon, S. M., Ott, J. J., Van Damme, P. & Shouval, D. Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J. Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2017.08.034 (2017).","journal-title":"J. Hepatol."},{"key":"461_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000252779","volume":"53","author":"SH Jeong","year":"2010","unstructured":"Jeong, S. H. & Lee, H. S. Hepatitis A: clinical manifestations and management. Intervirology 53, 15\u201319 (2010).","journal-title":"Intervirology"},{"key":"461_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1053\/j.gastro.2006.01.007","volume":"130","author":"E Elinav","year":"2006","unstructured":"Elinav, E. et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 130, 1129\u20131134 (2006).","journal-title":"Gastroenterology"},{"key":"461_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5468\/ogs.2013.56.6.368","volume":"56","author":"GJ Cho","year":"2013","unstructured":"Cho, G. J. et al. Hepatitis A virus infection during pregnancy in Korea: hepatitis A infection on pregnant women. Obstet. Gynecol. Sci. 56, 368\u2013374 (2013).","journal-title":"Obstet. Gynecol. Sci."},{"key":"461_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41575-020-00361-w","volume":"18","author":"NA Terrault","year":"2021","unstructured":"Terrault, N. A., Levy, M. T., Cheung, K. W. & Jourdain, G. Viral hepatitis and pregnancy. Nat. Rev. Gastroenterol. Hepatol. 18, 117\u2013130 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"461_CR8","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031708","author":"EC Shin","year":"2018","unstructured":"Shin, E. C. & Jeong, S. H. Natural history, clinical manifestations, and pathogenesis of hepatitis A. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a031708 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"461_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6905a1","volume":"69","author":"NP Nelson","year":"2020","unstructured":"Nelson, N. P. et al. Prevention of hepatitis A virus infection in the United States: recommendations of the advisory committee on immunization practices, 2020. MMWR Recomm. Rep. 69, 1\u201338 (2020).","journal-title":"MMWR Recomm. Rep."},{"key":"461_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/hep.27537","volume":"61","author":"MG Collier","year":"2015","unstructured":"Collier, M. G., Tong, X. & Xu, F. Hepatitis A hospitalizations in the United States, 2002-2011. Hepatology 61, 481\u2013485 (2015).","journal-title":"Hepatology"},{"key":"461_CR11","unstructured":"World Health Organization. WHO Position Paper on Hepatitis A Vaccines. WHO https:\/\/www.who.int\/publications\/i\/item\/who-wer9740-493-512 (2022)."},{"key":"461_CR12","unstructured":"Institute for Health Metrics and Evaluation. Global Burden of Disease (2019). Institute for Health Metrics and Evaluation http:\/\/ghdx.healthdata.org\/gbd-results-tool (2022)."},{"key":"461_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1542\/peds.105.2.436","volume":"105","author":"U Shah","year":"2000","unstructured":"Shah, U., Habib, Z. & Kleinman, R. E. Liver failure attributable to hepatitis A virus infection in a developing country. Pediatrics 105, 436\u2013438 (2000).","journal-title":"Pediatrics"},{"key":"461_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1478-3231.2007.01634.x","volume":"28","author":"MS Munn\u00e9","year":"2008","unstructured":"Munn\u00e9, M. S. et al. Molecular characterization of hepatitis A virus in children with fulminant hepatic failure in Argentina. Liver Int. 28, 47\u201353 (2008).","journal-title":"Liver Int."},{"key":"461_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031716","author":"KH Jacobsen","year":"2018","unstructured":"Jacobsen, K. H. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a031716 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"461_CR16","unstructured":"World Health Organization. The Global Prevalence of Hepatitis A Virus Infection and Susceptibility. WHO https:\/\/www.who.int\/publications\/i\/item\/the-global-prevalence-of-hepatitis-a-virus-infection-and-susceptibility (2009)."},{"key":"461_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268469","volume":"17","author":"A Guzman-Holst","year":"2022","unstructured":"Guzman-Holst, A. et al. Burden of disease and associated complications of hepatitis A in children and adults in Mexico: a retrospective database study. PLoS ONE 17, e0268469 (2022).","journal-title":"PLoS ONE"},{"key":"461_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.1994.03520110065031","volume":"272","author":"R Steffen","year":"1994","unstructured":"Steffen, R. et al. Epidemiology and prevention of hepatitis A in travelers. JAMA 272, 885\u2013889 (1994).","journal-title":"JAMA"},{"key":"461_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/MAJ.0b013e3181425411","volume":"334","author":"AS Craig","year":"2007","unstructured":"Craig, A. S. et al. Hepatitis A outbreak activity in the United States: responding to a vaccine-preventable disease. Am. J. Med. Sci. 334, 180\u2013183 (2007).","journal-title":"Am. J. Med. Sci."},{"key":"461_CR20","unstructured":"European Centre for Disease Control and Prevention. Hepatitis A Annual Epidemiological Report \u2014 2021. ECDC https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hepatitis-annual-epidemiological-report-2021 (2022)."},{"key":"461_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/infdis\/jiu834","volume":"212","author":"KN Ly","year":"2015","unstructured":"Ly, K. N. & Klevens, R. M. Trends in disease and complications of hepatitis A virus infection in the United States, 1999-2011: a new concern for adults. J. Infect. Dis. 212, 176\u2013182 (2015).","journal-title":"J. Infect. Dis."},{"key":"461_CR22","unstructured":"European Centre for Disease Prevention and Control. Hepatitis A \u2014 Annual Epidemiological Report for 2019. ECDC https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hepatitis-annual-epidemiological-report-2019 (2022)."},{"key":"461_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15585\/mmwr.su6501a6","volume":"65","author":"TV Murphy","year":"2016","unstructured":"Murphy, T. V. et al. Progress toward eliminating hepatitis A disease in the United States. MMWR Suppl. 65, 29\u201341 (2016).","journal-title":"MMWR Suppl."},{"key":"461_CR24","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.15585\/mmwr.mm7139a1","volume":"71","author":"MA Foster","year":"2022","unstructured":"Foster, M. A. et al. Widespread hepatitis A outbreaks associated with person-to-person transmission \u2014 United States, 2016-2020. MMWR Morb. Mortal. Wkly Rep. 71, 1229\u20131234 (2022).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"461_CR25","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.15585\/mmwr.mm6743a3","volume":"67","author":"M Foster","year":"2018","unstructured":"Foster, M. et al. Hepatitis A virus outbreaks associated with drug use and homelessness \u2014 California, Kentucky, Michigan, and Utah, 2017. MMWR Morb. Mortal. Wkly Rep. 67, 1208\u20131210 (2018).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"461_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.15585\/mmwr.mm6818a2","volume":"68","author":"MA Foster","year":"2019","unstructured":"Foster, M. A. et al. Increase in hepatitis A virus infections \u2014 United States, 2013-2018. MMWR Morb. Mortal. Wkly Rep. 68, 413\u2013415 (2019).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"461_CR27","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2019.24.28.1800397","author":"T Enkirch","year":"2019","unstructured":"Enkirch, T. et al. Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union\/European Economic Area: towards comparable sequencing of hepatitis A virus. Eur. Surveill. https:\/\/doi.org\/10.2807\/1560-7917.Es.2019.24.28.1800397 (2019).","journal-title":"Eur. Surveill."},{"key":"461_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13821","author":"A Andani","year":"2023","unstructured":"Andani, A. et al. Hepatitis A occurrence and outbreaks in Europe over the past two decades: a systematic review. J. Viral Hepat. https:\/\/doi.org\/10.1111\/jvh.13821 (2023).","journal-title":"J. Viral Hepat."},{"key":"461_CR29","first-page":"7","volume":"1","author":"DAS Lesmanawati","year":"2020","unstructured":"Lesmanawati,D. A. S., Hooshmand, E., Moa, A., Kunasekaran, M. P. & MacIntyre, C. R. The global epidemiology of hepatitis A outbreaks 2016-2018 and the utiliy of EpiWATCH as a rapid epidemic intelligence service. Glob. Biosecurity 1, 7 (2020).","journal-title":"Glob. Biosecurity"},{"key":"461_CR30","doi-asserted-by":"publisher","first-page":"e01180-15","DOI":"10.1128\/mBio.01180-15","volume":"6","author":"SJ Anthony","year":"2015","unstructured":"Anthony, S. J. et al. Discovery of a novel hepatovirus (Phopivirus of seals) related to human hepatitis A virus.\u00a0mBio 6, e01180-15 (2015).","journal-title":"mBio"},{"key":"461_CR31","doi-asserted-by":"publisher","first-page":"15190","DOI":"10.1073\/pnas.1516992112","volume":"112","author":"JF Drexler","year":"2015","unstructured":"Drexler, J. F. et al. Evolutionary origins of hepatitis A virus in small mammals. Proc. Natl Acad. Sci. USA 112, 15190\u201315195 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"461_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep22361","volume":"6","author":"JM Yu","year":"2016","unstructured":"Yu, J. M. et al. A novel hepatovirus identified in wild woodchuck Marmota himalayana. Sci. Rep. 6, 22361 (2016).","journal-title":"Sci. Rep."},{"key":"461_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12250-018-0013-6","volume":"33","author":"W Li","year":"2018","unstructured":"Li, W. et al. Genomic characterization of a novel hepatovirus from great roundleaf bats in China. Virol. Sin. 33, 108\u2013110 (2018).","journal-title":"Virol. Sin."},{"key":"461_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00082-18","author":"I de Oliveira Carneiro","year":"2018","unstructured":"de Oliveira Carneiro, I. et al. A novel marsupial hepatitis A virus corroborates complex evolutionary patterns shaping the genus hepatovirus. J. Virol. https:\/\/doi.org\/10.1128\/jvi.00082-18 (2018).","journal-title":"J. Virol."},{"key":"461_CR35","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031690","author":"AL Sander","year":"2018","unstructured":"Sander, A. L., Corman, V. M., Lukashev, A. N. & Drexler, J. F. Evolutionary origins of enteric hepatitis viruses. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a031690 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"461_CR36","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.1128\/jvi.65.11.5828-5838.1991","volume":"65","author":"EA Brown","year":"1991","unstructured":"Brown, E. A., Day, S. P., Jansen, R. W. & Lemon, S. M. The 5\u2032 nontranslated region of hepatitis A virus RNA: secondary structure and elements required for translation in vitro. J. Virol. 65, 5828\u20135838 (1991).","journal-title":"J. Virol."},{"key":"461_CR37","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1128\/jvi.68.8.5253-5263.1994","volume":"68","author":"LE Whetter","year":"1994","unstructured":"Whetter, L. E., Day, S. P., Elroy-Stein, O., Brown, E. A. & Lemon, S. M. Low efficiency of the 5\u2032 nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J. Virol. 68, 5253\u20135263 (1994).","journal-title":"J. Virol."},{"key":"461_CR38","doi-asserted-by":"publisher","first-page":"7854","DOI":"10.1128\/JVI.75.17.7854-7863.2001","volume":"75","author":"IK Ali","year":"2001","unstructured":"Ali, I. K., McKendrick, L., Morley, S. J. & Jackson, R. J. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G. J. Virol. 75, 7854\u20137863 (2001).","journal-title":"J. Virol."},{"key":"461_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000797","volume":"6","author":"L Aragones","year":"2010","unstructured":"Aragones, L., Guix, S., Ribes, E., Bosch, A. & Pinto, R. M. Fine-tuning translation kinetics selection as the driving force of codon usage bias in the hepatitis A virus capsid. PLoS Pathog. 6, e1000797 (2010).","journal-title":"PLoS Pathog."},{"key":"461_CR40","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1128\/JVI.00087-14","volume":"88","author":"MI Costafreda","year":"2014","unstructured":"Costafreda, M. I. et al. Hepatitis A virus adaptation to cellular shutoff is driven by dynamic adjustments of codon usage and results in the selection of populations with altered capsids. J. Virol. 88, 5029\u20135041 (2014).","journal-title":"J. Virol."},{"key":"461_CR41","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/gbe\/evz146","volume":"11","author":"L D\u2019Andrea","year":"2019","unstructured":"D\u2019Andrea, L. et al. The critical role of codon composition on the translation efficiency robustness of the hepatitis A virus capsid. Genome Biol. Evol. 11, 2439\u20132456 (2019).","journal-title":"Genome Biol. Evol."},{"key":"461_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005969","volume":"4","author":"BD Greenbaum","year":"2009","unstructured":"Greenbaum, B. D., Rabadan, R. & Levine, A. J. Patterns of oligonucleotide sequences in viral and host cell RNA identify mediators of the host innate immune system. PLoS ONE 4, e5969 (2009).","journal-title":"PLoS ONE"},{"key":"461_CR43","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1128\/aem.60.10.3704-3710.1994","volume":"60","author":"FX Abad","year":"1994","unstructured":"Abad, F. X., Pinto, R. M. & Bosch, A. Survival of enteric viruses on environmental fomites. Appl. Environ. Microbiol. 60, 3704\u20133710 (1994).","journal-title":"Appl. Environ. Microbiol."},{"key":"461_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature13806","volume":"517","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. Hepatitis A virus and the origins of picornaviruses. Nature 517, 85\u201388 (2015).","journal-title":"Nature"},{"key":"461_CR45","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1073\/pnas.1616502114","volume":"114","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Potent neutralization of hepatitis A virus reveals a receptor mimic mechanism and the receptor recognition site. Proc. Natl Acad. Sci. USA 114, 770\u2013775 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"461_CR46","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031807","author":"DI Stuart","year":"2019","unstructured":"Stuart, D. I., Ren, J., Wang, X., Rao, Z. & Fry, E. E. Hepatitis A virus capsid structure. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a031807 (2019).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"461_CR47","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/jvi.66.4.2208-2216.1992","volume":"66","author":"LH Ping","year":"1992","unstructured":"Ping, L. H. & Lemon, S. M. Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J. Virol. 66, 2208\u20132216 (1992).","journal-title":"J. Virol."},{"key":"461_CR48","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/0042-6822(92)90277-V","volume":"191","author":"OV Nainan","year":"1992","unstructured":"Nainan, O. V., Brinton, M. A. & Margolis, H. S. Identification of amino acids located in the antibody binding sites of human hepatitis A virus. Virology 191, 984\u2013987 (1992).","journal-title":"Virology"},{"key":"461_CR49","doi-asserted-by":"publisher","first-page":"9807","DOI":"10.1128\/JVI.78.18.9807-9813.2004","volume":"78","author":"G Sanchez","year":"2004","unstructured":"Sanchez, G. et al. Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane. J. Virol. 78, 9807\u20139813 (2004).","journal-title":"J. Virol."},{"key":"461_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF01318357","volume":"113","author":"D Crevat","year":"1990","unstructured":"Crevat, D. et al. Monoclonal antibodies against an immunodominant and neutralizing epitope on hepatitis A virus antigen. Arch. Virol. 113, 95\u201398 (1990).","journal-title":"Arch. Virol."},{"key":"461_CR51","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1128\/JVI.77.1.452-459.2003","volume":"77","author":"G Sanchez","year":"2003","unstructured":"Sanchez, G., Bosch, A. & Pint\u00f3, R. M. Genome variability and capsid structural constraints of hepatitis A virus. J. Virol. 77, 452\u2013459 (2003).","journal-title":"J. Virol."},{"key":"461_CR52","doi-asserted-by":"publisher","first-page":"a031781","DOI":"10.1101\/cshperspect.a031781","volume":"8","author":"RM Pinto","year":"2018","unstructured":"Pinto, R. M. et al. Hepatitis A virus codon usage: implications for translation kinetics and capsid folding. Cold Spring Harb. Perspect. Med. 8, a031781 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"461_CR53","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1128\/JVI.01842-07","volume":"82","author":"L Aragones","year":"2008","unstructured":"Aragones, L., Bosch, A. & Pinto, R. M. Hepatitis A virus mutant spectra under the selective pressure of monoclonal antibodies: codon usage constraints limit capsid variability. J. Virol. 82, 1688\u20131700 (2008).","journal-title":"J. Virol."},{"key":"461_CR54","doi-asserted-by":"publisher","first-page":"11223","DOI":"10.1073\/pnas.1101939108","volume":"108","author":"RE Lanford","year":"2011","unstructured":"Lanford, R. E. et al. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc. Natl Acad. Sci. USA 108, 11223\u201311228 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"461_CR55","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1002\/j.1460-2075.1996.tb00803.x","volume":"15","author":"G Kaplan","year":"1996","unstructured":"Kaplan, G. et al. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 15, 4282\u20134296 (1996).","journal-title":"EMBO J."},{"key":"461_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00969-17","author":"A Das","year":"2017","unstructured":"Das, A. et al. TIM1 (HAVCR1) is not essential for cellular entry of either quasi-enveloped or naked hepatitis A virions. mBio https:\/\/doi.org\/10.1128\/mBio.00969-17 (2017).","journal-title":"mBio"},{"key":"461_CR57","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41564-020-0727-8","volume":"5","author":"A Das","year":"2020","unstructured":"Das, A. et al. Gangliosides are essential endosomal receptors for quasi-enveloped and naked hepatitis A virus. Nat. Microbiol. 5, 1069\u20131078 (2020).","journal-title":"Nat. Microbiol."},{"key":"461_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00889-z","author":"A Das","year":"2023","unstructured":"Das, A. et al. Cell entry and release of quasi-enveloped human hepatitis viruses. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/s41579-023-00889-z (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"461_CR59","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1128\/jvi.60.1.124-130.1986","volume":"60","author":"M Weitz","year":"1986","unstructured":"Weitz, M., Baroudy, B. M., Maloy, W. L., Ticehurst, J. R. & Purcell, R. H. Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs. J. Virol. 60, 124\u2013130 (1986).","journal-title":"J. Virol."},{"key":"461_CR60","doi-asserted-by":"publisher","first-page":"10118","DOI":"10.1128\/JVI.00787-08","volume":"82","author":"Y Yang","year":"2008","unstructured":"Yang, Y., Yi, M., Evans, D. J., Simmonds, P. & Lemon, S. M. Identification of a conserved RNA replication element (cre) within the 3Dpol-coding sequence of hepatoviruses. J. Virol. 82, 10118\u201310128 (2008).","journal-title":"J. Virol."},{"key":"461_CR61","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1074\/jbc.274.8.4527","volume":"274","author":"C Probst","year":"1999","unstructured":"Probst, C., Jecht, M. & Gauss-Muller, V. Intrinsic signals for the assembly of hepatitis A virus particles. Role of structural proteins VP4 and 2A. J. Biol. Chem. 274, 4527\u20134531 (1999).","journal-title":"J. Biol. Chem."},{"key":"461_CR62","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature12029","volume":"496","author":"Z Feng","year":"2013","unstructured":"Feng, Z. et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496, 367\u2013371 (2013).","journal-title":"Nature"},{"key":"461_CR63","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01998-16","author":"A Hirai-Yuki","year":"2016","unstructured":"Hirai-Yuki, A., Hensley, L., Whitmire, J. K. & Lemon, S. M. Biliary secretion of quasi-enveloped human hepatitis A virus. mBio https:\/\/doi.org\/10.1128\/mBio.01998-16 (2016).","journal-title":"mBio"},{"key":"461_CR64","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1128\/JVI.73.7.6015-6023.1999","volume":"73","author":"J Graff","year":"1999","unstructured":"Graff, J. et al. Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J. Virol. 73, 6015\u20136023 (1999).","journal-title":"J. Virol."},{"key":"461_CR65","doi-asserted-by":"publisher","first-page":"6220","DOI":"10.1128\/JVI.73.8.6220-6227.1999","volume":"73","author":"A Martin","year":"1999","unstructured":"Martin, A., Benichou, D., Chao, S. F., Cohen, L. M. & Lemon, S. M. Maturation of the hepatitis A virus capsid protein VP1 is not dependent on processing by the 3Cpro proteinase. J. Virol. 73, 6220\u20136227 (1999).","journal-title":"J. Virol."},{"key":"461_CR66","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1073\/pnas.1704390114","volume":"114","author":"BC Avanzino","year":"2017","unstructured":"Avanzino, B. C., Fuchs, G. & Fraser, C. S. Cellular cap-binding protein, eIF4E, promotes picornavirus genome restructuring and translation. Proc. Natl Acad. Sci. USA 114, 9611\u20139616 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"461_CR67","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1128\/jvi.67.11.6716-6725.1993","volume":"67","author":"KH Chang","year":"1993","unstructured":"Chang, K. H., Brown, E. A. & Lemon, S. M. Cell type-specific proteins which interact with the 5\u2032 nontranslated region of hepatitis A virus RNA. J. Virol. 67, 6716\u20136725 (1993).","journal-title":"J. Virol."},{"key":"461_CR68","doi-asserted-by":"publisher","first-page":"9668","DOI":"10.1128\/JVI.72.12.9668-9675.1998","volume":"72","author":"J Graff","year":"1998","unstructured":"Graff, J., Cha, J., Blyn, L. B. & Ehrenfeld, E. Interaction of poly(rC) binding protein 2 with the 5\u2032 noncoding region of hepatitis A virus RNA and its effects on translation. J. Virol. 72, 9668\u20139675 (1998).","journal-title":"J. Virol."},{"key":"461_CR69","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1128\/MCB.20.5.1583-1595.2000","volume":"20","author":"R Gosert","year":"2000","unstructured":"Gosert, R. et al. Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo. Mol. Cell Biol. 20, 1583\u20131595 (2000).","journal-title":"Mol. Cell Biol."},{"key":"461_CR70","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1128\/JVI.74.14.6459-6468.2000","volume":"74","author":"M Yi","year":"2000","unstructured":"Yi, M., Schultz, D. E. & Lemon, S. M. Functional significance of the interaction of hepatitis A virus RNA with glyceraldehyde 3-phosphate dehydrogenase (GAPDH): opposing effects of GAPDH and polypyrimidine tract binding protein on internal ribosome entry site function. J. Virol. 74, 6459\u20136468 (2000).","journal-title":"J. Virol."},{"key":"461_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101993","volume":"9","author":"X Jiang","year":"2014","unstructured":"Jiang, X. et al. Suppression of La antigen exerts potential antiviral effects against hepatitis A virus. PLoS ONE 9, e101993 (2014).","journal-title":"PLoS ONE"},{"key":"461_CR72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204511119","volume":"119","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. The ZCCHC14\/TENT4 complex is required for hepatitis A virus RNA synthesis. Proc. Natl Acad. Sci. USA 119, e2204511119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"461_CR73","doi-asserted-by":"publisher","first-page":"108859","DOI":"10.1016\/j.celrep.2021.108859","volume":"34","author":"J Kulsuptrakul","year":"2021","unstructured":"Kulsuptrakul, J., Wang, R., Meyers, N. L., Ott, M. & Puschnik, A. S. A genome-wide CRISPR screen identifies UFMylation and TRAMP-like complexes as host factors required for hepatitis A virus infection. Cell Rep. 34, 108859 (2021).","journal-title":"Cell Rep."},{"key":"461_CR74","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43983","author":"EE Rivera-Serrano","year":"2019","unstructured":"Rivera-Serrano, E. E., Gonz\u00e1lez-L\u00f3pez, O., Das, A. & Lemon, S. M. Cellular entry and uncoating of naked and quasi-enveloped human hepatoviruses. eLife https:\/\/doi.org\/10.7554\/eLife.43983 (2019).","journal-title":"eLife"},{"key":"461_CR75","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/cld.253","volume":"2","author":"C Phan","year":"2013","unstructured":"Phan, C. & Hollinger, F. B. Hepatitis A: natural history, immunopathogenesis, and outcome. Clin. Liver Dis. 2, 231\u2013234 (2013).","journal-title":"Clin. Liver Dis."},{"key":"461_CR76","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1055\/s-0030-1267534","volume":"30","author":"L Qu","year":"2010","unstructured":"Qu, L. & Lemon, S. M. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses. Semin. Liver Dis. 30, 319\u2013332 (2010).","journal-title":"Semin. Liver Dis."},{"key":"461_CR77","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.1073\/pnas.0611506104","volume":"104","author":"Y Yang","year":"2007","unstructured":"Yang, Y. et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl Acad. Sci. USA 104, 7253\u20137258 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"461_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002169","volume":"7","author":"L Qu","year":"2011","unstructured":"Qu, L. et al. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog. 7, e1002169 (2011).","journal-title":"PLoS Pathog."},{"key":"461_CR79","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1126\/science.aaf8325","volume":"353","author":"A Hirai-Yuki","year":"2016","unstructured":"Hirai-Yuki, A. et al. MAVS-dependent host species range and pathogenicity of human hepatitis A virus. Science 353, 1541\u20131545 (2016).","journal-title":"Science"},{"key":"461_CR80","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","volume":"27","author":"IN Crispe","year":"2009","unstructured":"Crispe, I. N. The liver as a lymphoid organ. Annu. Rev. Immunol. 27, 147\u2013163 (2009).","journal-title":"Annu. Rev. Immunol."},{"issue":"Suppl. 1","key":"461_CR81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/infdis\/171.Supplement_1.S9","volume":"171","author":"JT Stapleton","year":"1995","unstructured":"Stapleton, J. T. Host immune response to hepatitis A virus. J. Infect. Dis. 171 (Suppl. 1), 9\u201314 (1995).","journal-title":"J. Infect. Dis."},{"key":"461_CR82","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jmv.1890110404","volume":"11","author":"E Sikuler","year":"1983","unstructured":"Sikuler, E., Keynan, A., Hanuka, N., Friedman, M. G. & Sarov, I. Detection and persistence of specific IgA antibodies in serum of patients with hepatitis A by capture radioimmunoassay. J. Med. Virol. 11, 287\u2013294 (1983).","journal-title":"J. Med. Virol."},{"key":"461_CR83","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/infdis\/148.6.1033","volume":"148","author":"SM Lemon","year":"1983","unstructured":"Lemon, S. M. & Binn, L. N. Serum neutralizing antibody response to hepatitis A virus. J. Infect. Dis. 148, 1033\u20131039 (1983).","journal-title":"J. Infect. Dis."},{"key":"461_CR84","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033472","author":"CM Walker","year":"2018","unstructured":"Walker, C. M. Adaptive immune responses in hepatitis A virus and hepatitis E virus infections. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a033472 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"461_CR85","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI77527","volume":"125","author":"Z Feng","year":"2015","unstructured":"Feng, Z. et al. Human pDCs preferentially sense enveloped hepatitis A virions. J. Clin. Invest. 125, 169\u2013176 (2015).","journal-title":"J. Clin. Invest."},{"key":"461_CR86","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","volume":"19","author":"G Jego","year":"2003","unstructured":"Jego, G. et al. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19, 225\u2013234 (2003).","journal-title":"Immunity"},{"key":"461_CR87","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1084\/jem.20111906","volume":"209","author":"Y Zhou","year":"2012","unstructured":"Zhou, Y. et al. Dominance of the CD4+ T helper cell response during acute resolving hepatitis A virus infection. J. Exp. Med. 209, 1481\u20131492 (2012).","journal-title":"J. Exp. Med."},{"key":"461_CR88","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jhep.2010.07.010","volume":"54","author":"I Schulte","year":"2011","unstructured":"Schulte, I. et al. Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection. J. Hepatol. 54, 201\u2013208 (2011).","journal-title":"J. Hepatol."},{"key":"461_CR89","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coviro.2015.01.003","volume":"11","author":"CM Walker","year":"2015","unstructured":"Walker, C. M., Feng, Z. & Lemon, S. M. Reassessing immune control of hepatitis A virus. Curr. Opin. Virol. 11, 7\u201313 (2015).","journal-title":"Curr. Opin. Virol."},{"key":"461_CR90","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1053\/j.gastro.2017.11.277","volume":"154","author":"YS Choi","year":"2018","unstructured":"Choi, Y. S. et al. Tumor necrosis factor-producing T-regulatory cells are associated with severe liver injury in patients with acute hepatitis A. Gastroenterology 154, 1047\u20131060 (2018).","journal-title":"Gastroenterology"},{"key":"461_CR91","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2017.11.025","volume":"48","author":"J Kim","year":"2018","unstructured":"Kim, J. et al. Innate-like cytotoxic function of bystander-activated CD8+ T cells is associated with liver injury in acute hepatitis A. Immunity 48, 161\u2013173.e5 (2018).","journal-title":"Immunity"},{"key":"461_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009960","volume":"17","author":"L Sun","year":"2021","unstructured":"Sun, L. et al. IRF3-mediated pathogenicity in a murine model of human hepatitis A. PLoS Pathog. 17, e1009960 (2021).","journal-title":"PLoS Pathog."},{"key":"461_CR93","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jhep.2021.07.019","volume":"75","author":"I Misumi","year":"2021","unstructured":"Misumi, I. et al. T cells protect against hepatitis A virus infection and limit infection-induced liver injury. J. Hepatol. 75, 1323\u20131334 (2021).","journal-title":"J. Hepatol."},{"key":"461_CR94","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00005792-199201000-00002","volume":"71","author":"M Glikson","year":"1992","unstructured":"Glikson, M., Galun, E., Oren, R., Tur-Kaspa, R. & Shouval, D. Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine 71, 14\u201323 (1992).","journal-title":"Medicine"},{"key":"461_CR95","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/jmv.21822","volume":"82","author":"YM Jung","year":"2010","unstructured":"Jung, Y. M. et al. Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea. J. Med. Virol. 82, 1318\u20131326 (2010).","journal-title":"J. Med. Virol."},{"key":"461_CR96","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00439-020-02166-y","volume":"139","author":"E Jouanguy","year":"2020","unstructured":"Jouanguy, E. Human genetic basis of fulminant viral hepatitis. Hum. Genet. 139, 877\u2013884 (2020).","journal-title":"Hum. Genet."},{"key":"461_CR97","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI44182","volume":"121","author":"HY Kim","year":"2011","unstructured":"Kim, H. Y. et al. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J. Clin. Invest. 121, 1111\u20131118 (2011).","journal-title":"J. Clin. Invest."},{"key":"461_CR98","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.20190669","volume":"216","author":"S Belkaya","year":"2019","unstructured":"Belkaya, S. et al. Inherited IL-18BP deficiency in human fulminant viral hepatitis. J. Exp. Med. 216, 1777\u20131790 (2019).","journal-title":"J. Exp. Med."},{"key":"461_CR99","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s10875-022-01376-5","volume":"43","author":"CB Korol","year":"2023","unstructured":"Korol, C. B. et al. Fulminant viral hepatitis in two siblings with inherited IL-10RB deficiency. J. Clin. Immunol. 43, 406\u2013420 (2023).","journal-title":"J. Clin. Immunol."},{"key":"461_CR100","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1872-034X.2011.00919.x","volume":"42","author":"T Miyamura","year":"2012","unstructured":"Miyamura, T. et al. Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: recent trend of hepatitis A causing acute liver failure. Hepatol. Res. 42, 248\u2013253 (2012).","journal-title":"Hepatol. Res."},{"key":"461_CR101","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.3390\/ijms16046842","volume":"16","author":"L D\u2019Andrea","year":"2015","unstructured":"D\u2019Andrea, L. et al. Hepatitis A virus genotype distribution during a decade of universal vaccination of preadolescents. Int. J. Mol. Sci. 16, 6842\u20136854 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"461_CR102","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1080\/21505594.2021.1910442","volume":"12","author":"RM Pinto","year":"2021","unstructured":"Pinto, R. M. et al. Pathogenicity and virulence of hepatitis A virus. Virulence 12, 1174\u20131185 (2021).","journal-title":"Virulence"},{"key":"461_CR103","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/gut.51.1.82","volume":"51","author":"K Fujiwara","year":"2002","unstructured":"Fujiwara, K. et al. Association between severity of type A hepatitis and nucleotide variations in the 5\u2032 non-translated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions. Gut 51, 82\u201388 (2002).","journal-title":"Gut"},{"key":"461_CR104","doi-asserted-by":"publisher","first-page":"8551","DOI":"10.1128\/JVI.76.17.8551-8559.2002","volume":"76","author":"SU Emerson","year":"2002","unstructured":"Emerson, S. U. et al. Identification of VP1\/2A and 2C as virulence genes of hepatitis A virus and demonstration of genetic instability of 2C. J. Virol. 76, 8551\u20138559 (2002).","journal-title":"J. Virol."},{"key":"461_CR105","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/jhep.2003.50366","volume":"38","author":"G Rezende","year":"2003","unstructured":"Rezende, G. et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 38, 613\u2013618 (2003).","journal-title":"Hepatology"},{"key":"461_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130728","volume":"10","author":"HW Lee","year":"2015","unstructured":"Lee, H. W. et al. Clinical factors and viral load influencing severity of acute hepatitis A. PLoS ONE 10, e0130728 (2015).","journal-title":"PLoS ONE"},{"issue":"Suppl. 1","key":"461_CR107","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0264-410X(92)90533-P","volume":"10","author":"RS Koff","year":"1992","unstructured":"Koff, R. S. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 10 (Suppl. 1), 15\u201317 (1992).","journal-title":"Vaccine"},{"key":"461_CR108","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1080\/21645515.2020.1819742","volume":"17","author":"C Herzog","year":"2021","unstructured":"Herzog, C., Van Herck, K. & Van Damme, P. Hepatitis A vaccination and its immunological and epidemiological long-term effects \u2014 a review of the evidence. Hum. Vaccin. Immunother. 17, 1496\u20131519 (2021).","journal-title":"Hum. Vaccin. Immunother."},{"key":"461_CR109","first-page":"681","volume":"24","author":"Y Lysy","year":"1988","unstructured":"Lysy, Y., Furst, A., Medina, A., Horenstein, E. & Shouval, D. Fatal relapsing viral hepatitis A infection during pregnancy. Isr. J. Med. Sci. 24, 681\u2013683 (1988).","journal-title":"Isr. J. Med. Sci."},{"key":"461_CR110","doi-asserted-by":"publisher","first-page":"105059","DOI":"10.1016\/j.jcv.2021.105059","volume":"146","author":"L Mouna","year":"2022","unstructured":"Mouna, L. et al. Accuracy assessment of total or IgG Immunoglobulin to hepatitis A virus tests around immunity threshold. J. Clin. Virol. 146, 105059 (2022).","journal-title":"J. Clin. Virol."},{"key":"461_CR111","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228356","author":"M Valota","year":"2019","unstructured":"Valota, M., Thienemann, F. & Misselwitz, B. False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2018-228356 (2019).","journal-title":"BMJ Case Rep."},{"key":"461_CR112","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.12998\/wjcc.v9.i22.6464","volume":"9","author":"J Yan","year":"2021","unstructured":"Yan, J. et al. False positive anti-hepatitis A virus immunoglobulin M in autoimmune hepatitis\/primary biliary cholangitis overlap syndrome: a case report. World J. Clin. Cases 9, 6464\u20136468 (2021).","journal-title":"World J. Clin. Cases"},{"key":"461_CR113","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1590\/S0036-46652000000400004","volume":"42","author":"IT Oba","year":"2000","unstructured":"Oba, I. T. et al. Detection of hepatitis A antibodies by ELISA using saliva as clinical samples. Rev. Inst. Med. Trop. Sao Paulo 42, 197\u2013200 (2000).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"461_CR114","doi-asserted-by":"publisher","first-page":"10950","DOI":"10.1128\/JVI.74.23.10950-10957.2000","volume":"74","author":"A Dotzauer","year":"2000","unstructured":"Dotzauer, A. et al. Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J. Virol. 74, 10950\u201310957 (2000).","journal-title":"J. Virol."},{"key":"461_CR115","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1099\/vir.0.038406-0","volume":"93","author":"A Dotzauer","year":"2012","unstructured":"Dotzauer, A. et al. The role of immunoglobulin A in prolonged and relapsing hepatitis A virus infections. J. Gen. Virol. 93, 754\u2013760 (2012).","journal-title":"J. Gen. Virol."},{"issue":"Suppl. 2","key":"461_CR116","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00001721-199506002-00007","volume":"6","author":"BH Robertson","year":"1995","unstructured":"Robertson, B. H. et al. Hepatitis A virus and polymerase chain reaction amplification: methodology and results. Blood Coagul. Fibrinolysis 6 (Suppl. 2), 27\u201331 (1995).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"461_CR117","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1128\/CMR.19.1.63-79.2006","volume":"19","author":"OV Nainan","year":"2006","unstructured":"Nainan, O. V., Xia, G., Vaughan, G. & Margolis, H. S. Diagnosis of hepatitis a virus infection: a molecular approach. Clin. Microbiol. Rev. 19, 63\u201379 (2006).","journal-title":"Clin. Microbiol. Rev."},{"key":"461_CR118","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2018.23.23.1800265","author":"IH Friesema","year":"2018","unstructured":"Friesema, I. H. et al. Spillover of a hepatitis A outbreak among men who have sex with men (MSM) to the general population, the Netherlands, 2017. Eur. Surveill. https:\/\/doi.org\/10.2807\/1560-7917.Es.2018.23.23.1800265 (2018).","journal-title":"Eur. Surveill."},{"key":"461_CR119","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2021.26.6.2000001","author":"Y Gozlan","year":"2021","unstructured":"Gozlan, Y. et al. Lessons from intensified surveillance of viral hepatitis A, Israel, 2017 and 2018. Eur. Surveill. https:\/\/doi.org\/10.2807\/1560-7917.Es.2021.26.6.2000001 (2021).","journal-title":"Eur. Surveill."},{"key":"461_CR120","doi-asserted-by":"publisher","first-page":"108986","DOI":"10.1016\/j.ijfoodmicro.2020.108986","volume":"338","author":"G Di Cola","year":"2021","unstructured":"Di Cola, G., Fantilli, A. C., Pisano, M. B. & R\u00e9, V. E. Foodborne transmission of hepatitis A and hepatitis E viruses: a literature review. Int. J. Food Microbiol. 338, 108986 (2021).","journal-title":"Int. J. Food Microbiol."},{"key":"461_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/v14010159","author":"RA Kozak","year":"2022","unstructured":"Kozak, R. A. et al. Development and evaluation of a molecular hepatitis A virus assay for serum and stool specimens. Viruses https:\/\/doi.org\/10.3390\/v14010159 (2022).","journal-title":"Viruses"},{"key":"461_CR122","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000149554","volume":"22","author":"G Siegl","year":"1984","unstructured":"Siegl, G., Weitz, M. & Kronauer, G. Stability of hepatitis A virus. Intervirology 22, 218\u2013226 (1984).","journal-title":"Intervirology"},{"key":"461_CR123","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1017\/S095026880006177X","volume":"98","author":"TM Reid","year":"1987","unstructured":"Reid, T. M. & Robinson, H. G. Frozen raspberries and hepatitis A. Epidemiol. Infect. 98, 109\u2013112 (1987).","journal-title":"Epidemiol. Infect."},{"key":"461_CR124","first-page":"159","volume":"11","author":"SA Sattar","year":"2000","unstructured":"Sattar, S. A., Jason, T., Bidawid, S. & Farber, J. Foodborne spread of hepatitis A: recent studies on virus survival, transfer and inactivation. Can. J. Infect. Dis. 11, 159\u2013163 (2000).","journal-title":"Can. J. Infect. Dis."},{"key":"461_CR125","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1128\/jcm.16.5.957-958.1982","volume":"16","author":"KA McCaustland","year":"1982","unstructured":"McCaustland, K. A., Bond, W. W., Bradley, D. W., Ebert, J. W. & Maynard, J. E. Survival of hepatitis A virus in feces after drying and storage for 1 month. J. Clin. Microbiol. 16, 957\u2013958 (1982).","journal-title":"J. Clin. Microbiol."},{"key":"461_CR126","first-page":"2162","volume":"73","author":"SC Brundage","year":"2006","unstructured":"Brundage, S. C. & Fitzpatrick, A. N. Hepatitis A. Am. Fam. Physician 73, 2162\u20132168 (2006).","journal-title":"Am. Fam. Physician"},{"key":"461_CR127","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12560-018-9349-1","volume":"10","author":"N Cook","year":"2018","unstructured":"Cook, N., Bertrand, I., Gantzer, C., Pinto, R. M. & Bosch, A. Persistence of hepatitis A virus in fresh produce and production environments, and the effect of disinfection procedures: a review. Food Environ. Virol. 10, 253\u2013262 (2018).","journal-title":"Food Environ. Virol."},{"key":"461_CR128","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.coviro.2011.11.003","volume":"2","author":"KR Wigginton","year":"2012","unstructured":"Wigginton, K. R. & Kohn, T. Virus disinfection mechanisms: the role of virus composition, structure, and function. Curr. Opin. Virol. 2, 84\u201389 (2012).","journal-title":"Curr. Opin. Virol."},{"key":"461_CR129","doi-asserted-by":"publisher","first-page":"109529","DOI":"10.1016\/j.ijfoodmicro.2021.109529","volume":"364","author":"E Jubinville","year":"2022","unstructured":"Jubinville, E., Trudel-Ferland, M., Amyot, J. & Jean, J. Inactivation of hepatitis A virus and norovirus on berries by broad-spectrum pulsed light. Int. J. Food Microbiol. 364, 109529 (2022).","journal-title":"Int. J. Food Microbiol."},{"key":"461_CR130","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1128\/AEM.66.7.2759-2763.2000","volume":"66","author":"S Bidawid","year":"2000","unstructured":"Bidawid, S., Farber, J. M. & Sattar, S. A. Contamination of foods by food handlers: experiments on hepatitis A virus transfer to food and its interruption. Appl. Environ. Microbiol. 66, 2759\u20132763 (2000).","journal-title":"Appl. Environ. Microbiol."},{"key":"461_CR131","doi-asserted-by":"publisher","first-page":"708","DOI":"10.26444\/aaem\/99590","volume":"25","author":"T Ahmad","year":"2018","unstructured":"Ahmad, T. et al. Assessment of the risk for human health of enterovirus and hepatitis A virus in clinical and water sources from three metropolitan cities of Pakistan. Ann. Agric. Environ. Med. 25, 708\u2013713 (2018).","journal-title":"Ann. Agric. Environ. Med."},{"key":"461_CR132","first-page":"574","volume":"215","author":"Y Manor","year":"2017","unstructured":"Manor, Y. et al. Evidence for hepatitis A virus endemic circulation in Israel despite universal toddlers\u2019 vaccination since 1999 and low clinical incidence in all age groups. J. Infect. Dis. 215, 574\u2013580 (2017).","journal-title":"J. Infect. Dis."},{"key":"461_CR133","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004181.pub2","author":"JP Liu","year":"2009","unstructured":"Liu, J. P., Nikolova, D. & Fei, Y. Immunoglobulins for preventing hepatitis A. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD004181.pub2 (2009).","journal-title":"Cochrane Database Syst. Rev."},{"key":"461_CR134","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jama.1948.02900050004002","volume":"138","author":"J Stokes Jr","year":"1948","unstructured":"Stokes, J. Jr & Blanchard, M. et al. Methods of protection against homologous serum hepatitis; studies on the protective value of gamma globulin in homologous serum hepatitis Sh virus. J. Am. Med. Assoc. 138, 336\u2013341 (1948).","journal-title":"J. Am. Med. Assoc."},{"issue":"Suppl. 1","key":"461_CR135","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0264-410X(92)90541-Q","volume":"10","author":"JT Stapleton","year":"1992","unstructured":"Stapleton, J. T. Passive immunization against hepatitis A. Vaccine 10 (Suppl. 1), 45\u201347 (1992).","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"461_CR136","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0168-8278(05)80375-7","volume":"18","author":"D Shouval","year":"1993","unstructured":"Shouval, D. et al. Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin. J. Hepatol. 18 (Suppl. 2), 32\u201337 (1993).","journal-title":"J. Hepatol."},{"key":"461_CR137","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaci.2011.06.047","volume":"129","author":"R Rachid","year":"2012","unstructured":"Rachid, R. & Bonilla, F. A. The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature. J. Allergy Clin. Immunol. 129, 628\u2013634 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"461_CR138","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/0140-6736(91)92834-O","volume":"337","author":"D Howell","year":"1991","unstructured":"Howell, D., Barbara, J. A. & Brennan, M. Hepatitis A virus, blood donors, and immunoglobulin preparations. Lancet 337, 1165 (1991).","journal-title":"Lancet"},{"key":"461_CR139","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2165\/00019053-200826010-00003","volume":"26","author":"AM Anonychuk","year":"2008","unstructured":"Anonychuk, A. M. et al. Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies. Pharmacoeconomics 26, 17\u201332 (2008).","journal-title":"Pharmacoeconomics"},{"key":"461_CR140","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1056\/NEJM199208133270702","volume":"327","author":"A Werzberger","year":"1992","unstructured":"Werzberger, A. et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N. Engl. J. Med. 327, 453\u2013457 (1992).","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"461_CR141","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0264-410X(93)90151-M","volume":"11","author":"D Shouval","year":"1993","unstructured":"Shouval, D. et al. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis. Vaccine 11 (Suppl. 1), 9\u201314 (1993).","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"461_CR142","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0168-8278(05)80372-1","volume":"18","author":"SM Lemon","year":"1993","unstructured":"Lemon, S. M. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine. J. Hepatol. 18 (Suppl. 2), 15\u201319 (1993).","journal-title":"J. Hepatol."},{"key":"461_CR143","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/01.inf.0000253253.85640.cc","volume":"26","author":"BP Bell","year":"2007","unstructured":"Bell, B. P. et al. Immunogenicity of an inactivated hepatitis A vaccine in infants and young children. Pediatr. Infect. Dis. J. 26, 116\u2013122 (2007).","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"Suppl. 1","key":"461_CR144","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/infdis\/171.Supplement_1.S44","volume":"171","author":"R Clemens","year":"1995","unstructured":"Clemens, R. et al. Clinical experience with an inactivated hepatitis A vaccine. J. Infect. Dis. 171 (Suppl. 1), 44\u201349 (1995).","journal-title":"J. Infect. Dis."},{"key":"461_CR145","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/infdis\/171.3.676","volume":"171","author":"BJ McMahon","year":"1995","unstructured":"McMahon, B. J. et al. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults. J. Infect. Dis. 171, 676\u2013679 (1995).","journal-title":"J. Infect. Dis."},{"key":"461_CR146","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1001\/jama.1994.03510410040030","volume":"271","author":"BL Innis","year":"1994","unstructured":"Innis, B. L. et al. Protection against hepatitis A by an inactivated vaccine. JAMA 271, 1328\u20131334 (1994).","journal-title":"JAMA"},{"key":"461_CR147","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.vaccine.2021.01.038","volume":"40","author":"A Andani","year":"2022","unstructured":"Andani, A. et al. One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: a systematic review. Vaccine 40, 196\u2013205 (2022).","journal-title":"Vaccine"},{"key":"461_CR148","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1002\/jmv.22200","volume":"83","author":"K Van Herck","year":"2011","unstructured":"Van Herck, K., Jacquet, J. M. & Van Damme, P. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years. J. Med. Virol. 83, 1885\u20131891 (2011).","journal-title":"J. Med. Virol."},{"key":"461_CR149","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1016\/j.vaccine.2015.07.008","volume":"33","author":"H Theeten","year":"2015","unstructured":"Theeten, H. et al. Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions. Vaccine 33, 5723\u20135727 (2015).","journal-title":"Vaccine"},{"key":"461_CR150","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1002\/jmv.26327","volume":"93","author":"M Ramaswamy","year":"2021","unstructured":"Ramaswamy, M. et al. Hepatitis A vaccine immunogenicity 25 years after vaccination in Alaska. J. Med. Virol. 93, 3991\u20133994 (2021).","journal-title":"J. Med. Virol."},{"key":"461_CR151","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0140-6736(03)14418-2","volume":"362","author":"P Van Damme","year":"2003","unstructured":"Van Damme, P. et al. Hepatitis A booster vaccination: is there a need? Lancet 362, 1065\u20131071 (2003).","journal-title":"Lancet"},{"key":"461_CR152","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jmv.1890440425","volume":"44","author":"P Van Damme","year":"1994","unstructured":"Van Damme, P. et al. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J. Med. Virol. 44, 446\u2013451 (1994).","journal-title":"J. Med. Virol."},{"key":"461_CR153","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/jmv.21883","volume":"82","author":"PA Bovier","year":"2010","unstructured":"Bovier, P. A. et al. Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine. J. Med. Virol. 82, 1629\u20131634 (2010).","journal-title":"J. Med. Virol."},{"key":"461_CR154","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.vaccine.2013.10.088","volume":"32","author":"N Hens","year":"2014","unstructured":"Hens, N., Habteab Ghebretinsae, A., Hardt, K., Van Damme, P. & Van Herck, K. Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults. Vaccine 32, 1507\u20131513 (2014).","journal-title":"Vaccine"},{"key":"461_CR155","doi-asserted-by":"publisher","first-page":"101479","DOI":"10.1016\/j.tmaid.2019.101479","volume":"32","author":"HM Garcia Garrido","year":"2019","unstructured":"Garcia Garrido, H. M. et al. Hepatitis A vaccine immunogenicity in patients using immunosuppressive drugs: a systematic review and meta-analysis. Travel Med. Infect. Dis. 32, 101479 (2019).","journal-title":"Travel Med. Infect. Dis."},{"key":"461_CR156","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.medmal.2020.09.016","volume":"51","author":"L No\u00ebl","year":"2021","unstructured":"No\u00ebl, L. et al. Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccine. Infect. Dis. Now 51, 94\u201396 (2021).","journal-title":"Infect. Dis. Now"},{"key":"461_CR157","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.vaccine.2021.11.037","volume":"40","author":"A Urue\u00f1a","year":"2022","unstructured":"Urue\u00f1a, A. et al. Humoral and cellular immune memory response 12 years following single dose vaccination against hepatitis A in Argentinian children. Vaccine 40, 114\u2013121 (2022).","journal-title":"Vaccine"},{"key":"461_CR158","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13819","author":"WI de Brito","year":"2023","unstructured":"de Brito, W. I. et al. Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine. J. Viral Hepat. https:\/\/doi.org\/10.1111\/jvh.13819 (2023).","journal-title":"J. Viral Hepat."},{"key":"461_CR159","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1016\/j.vaccine.2015.06.099","volume":"33","author":"JG Melga\u00e7o","year":"2015","unstructured":"Melga\u00e7o, J. G. et al. A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection. Vaccine 33, 3813\u20133820 (2015).","journal-title":"Vaccine"},{"key":"461_CR160","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1016\/j.vaccine.2021.01.049","volume":"39","author":"C Herzog","year":"2021","unstructured":"Herzog, C. Immune memory persistence is well documented for hepatitis A vaccines. Vaccine 39, 4775\u20134776 (2021).","journal-title":"Vaccine"},{"key":"461_CR161","doi-asserted-by":"crossref","unstructured":"Averhoff, F. M., Khudyakov, Y. & Nelson, N. P. In Plotkin\u2019s Vaccines (eds Plotkin, S. A., Orenstein, W. A., Offit, P.A. & Edwards, K. M.) Ch. 24, 319\u2013341 (Elsevier, 2018).","DOI":"10.1016\/B978-0-323-35761-6.00024-9"},{"key":"461_CR162","first-page":"5","volume":"17","author":"R Jiang","year":"2020","unstructured":"Jiang, R. et al. Adverse events induced by immunization of concomitant inoculation of freeze-dried hepatitis A (Live) vaccine with vaccines for national immunization program from surveillance data. Chin. J. Pharmacovigil. 17, 5 (2020).","journal-title":"Chin. J. Pharmacovigil."},{"key":"461_CR163","first-page":"5","volume":"25","author":"Q Zhu","year":"2019","unstructured":"Zhu, Q. et al. Study on immunity effect of single and simultaneous vaccination of live attenuated hepatitis A vaccine and MMR combined with live attenuated vaccine for children 18-23 months old immunogenicity of hepatitis A attenuated live vaccine, and measles, rubella and mumps combined attenuated live vaccine for standalone and simultaneous vaccination in 18-23-month-old children. Chin. J. Vaccines Immun. 25, 5 (2019).","journal-title":"Chin. J. Vaccines Immun."},{"key":"461_CR164","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.vaccine.2006.08.004","volume":"25","author":"XY Wang","year":"2007","unstructured":"Wang, X. Y. et al. Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up. Vaccine 25, 446\u2013449 (2007).","journal-title":"Vaccine"},{"key":"461_CR165","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3748\/wjg.v6.i6.829","volume":"6","author":"YL Zhao","year":"2000","unstructured":"Zhao, Y. L. et al. H2 strain attenuated live hepatitis A vaccines: protective efficacy in a hepatitis A outbreak. World J. Gastroenterol. 6, 829\u2013832 (2000).","journal-title":"World J. Gastroenterol."},{"key":"461_CR166","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.vaccine.2018.01.043","volume":"36","author":"X Sun","year":"2018","unstructured":"Sun, X. et al. The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016. Vaccine 36, 1279\u20131284 (2018).","journal-title":"Vaccine"},{"key":"461_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-019-0591-z","volume":"8","author":"XJ Sun","year":"2019","unstructured":"Sun, X. J. et al. Changes in the epidemiology of hepatitis A in three socio-economic regions of China, 1990-2017. Infect. Dis. Poverty 8, 80 (2019).","journal-title":"Infect. Dis. Poverty"},{"key":"461_CR168","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/hep.31429","volume":"73","author":"F Wang","year":"2021","unstructured":"Wang, F. et al. Changing epidemiology of hepatitis A in China: evidence from three national serological surveys and the national notifiable disease reporting system. Hepatology 73, 1251\u20131260 (2021).","journal-title":"Hepatology"},{"key":"461_CR169","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0264-410X(96)00304-0","volume":"15","author":"JS Mao","year":"1997","unstructured":"Mao, J. S. et al. Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans. Vaccine 15, 944\u2013947 (1997).","journal-title":"Vaccine"},{"key":"461_CR170","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s13312-021-2285-4","volume":"58","author":"S Bhave","year":"2021","unstructured":"Bhave, S. et al. Long term immunogenicity of single dose of live attenuated hepatitis A vaccine in Indian children \u2014 results of 15-year follow-up. Indian Pediatr. 58, 749\u2013752 (2021).","journal-title":"Indian Pediatr."},{"key":"461_CR171","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.vaccine.2017.11.036","volume":"36","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine. Vaccine 36, 114\u2013121 (2018).","journal-title":"Vaccine"},{"key":"461_CR172","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2188\/jea.JE20130022","volume":"24","author":"F Cui","year":"2014","unstructured":"Cui, F. et al. Development, production, and postmarketing surveillance of hepatitis A vaccines in China. J. Epidemiol. 24, 169\u2013177 (2014).","journal-title":"J. Epidemiol."},{"key":"461_CR173","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/21645515.2020.1769389","volume":"16","author":"L Zhang","year":"2020","unstructured":"Zhang, L. Hepatitis A vaccination. Hum. Vaccin. Immunother. 16, 1565\u20131573 (2020).","journal-title":"Hum. Vaccin. Immunother."},{"key":"461_CR174","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/jama.294.2.202","volume":"294","author":"R Dagan","year":"2005","unstructured":"Dagan, R. et al. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 294, 202\u2013210 (2005).","journal-title":"JAMA"},{"key":"461_CR175","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1097\/INF.0000000000001176","volume":"35","author":"R Dagan","year":"2016","unstructured":"Dagan, R. et al. Long-term serologic follow-up of children vaccinated with a pediatric formulation of virosomal hepatitis A vaccine administered with routine childhood vaccines at 12\u201315 months of age. Pediatr. Infect. Dis. J. 35, e220\u2013228 (2016).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"461_CR176","first-page":"1","volume":"58","author":"D Daniels","year":"2009","unstructured":"Daniels, D., Grytdal, S. & Wasley, A. Surveillance for acute viral hepatitis \u2014 United States, 2007. MMWR Surveill. Summ. 58, 1\u201327 (2009).","journal-title":"MMWR Surveill. Summ."},{"key":"461_CR177","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2893.2008.01029.x","volume":"15","author":"MN Vacchino","year":"2008","unstructured":"Vacchino, M. N. Incidence of hepatitis A in Argentina after vaccination. J. Viral Hepat. 15, 47\u201350 (2008).","journal-title":"J. Viral Hepat."},{"key":"461_CR178","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/HMER.S22309","volume":"3","author":"G Cervio","year":"2011","unstructured":"Cervio, G. et al. Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program. Hepat. Med. 3, 99\u2013106 (2011).","journal-title":"Hepat. Med."},{"key":"461_CR179","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijid.2020.02.001","volume":"93","author":"Y Guo","year":"2020","unstructured":"Guo, Y. et al. The impact of universal live attenuated hepatitis A vaccines in Henan, China, 2005\u20132018. Int. J. Infect. Dis. 93, 163\u2013167 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"461_CR180","unstructured":"World Health Organization. Meeting of the Strategic Advisory Group of Experts on Immunization, April 2022: Conclusions and Recommendations. WHO https:\/\/www.who.int\/publications\/i\/item\/who-wer9724-261-276 (2022)."},{"key":"461_CR181","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2807\/1560-7917.ES2015.20.7.21040","volume":"20","author":"H Levine","year":"2015","unstructured":"Levine, H., Kopel, E., Anis, E., Givon-Lavi, N. & Dagan, R. The impact of a national routine immunisation programme initiated in 1999 on hepatitis A incidence in Israel, 1993 to 2012. Eur. Surveill. 20, 3\u201310 (2015).","journal-title":"Eur. Surveill."},{"key":"461_CR182","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1016\/j.vaccine.2012.07.029","volume":"30","author":"LM Erhart","year":"2012","unstructured":"Erhart, L. M. & Ernst, K. C. The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988-2007). Vaccine 30, 6103\u20136110 (2012).","journal-title":"Vaccine"},{"key":"461_CR183","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.vaccine.2016.11.002","volume":"35","author":"C Thompson","year":"2017","unstructured":"Thompson, C., Dey, A., Fearnley, E., Polkinghorne, B. & Beard, F. Impact of the national targeted hepatitis A immunisation program in Australia: 2000\u20132014. Vaccine 35, 170\u2013176 (2017).","journal-title":"Vaccine"},{"key":"461_CR184","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/QCO.0000000000000188","volume":"28","author":"R Aggarwal","year":"2015","unstructured":"Aggarwal, R. & Goel, A. Hepatitis A: epidemiology in resource-poor countries. Curr. Opin. Infect. Dis. 28, 488\u2013496 (2015).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"461_CR185","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1586\/14760584.2013.851008","volume":"12","author":"AA Suwantika","year":"2013","unstructured":"Suwantika, A. A., Yegenoglu, S., Riewpaiboon, A., Tu, H. A. & Postma, M. J. Economic evaluations of hepatitis A vaccination in middle-income countries. Expert Rev. Vaccines 12, 1479\u20131494 (2013).","journal-title":"Expert Rev. Vaccines"},{"key":"461_CR186","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/21645515.2015.1065362","volume":"12","author":"F Carlos","year":"2016","unstructured":"Carlos, F., G\u00f3mez, J. A., Anaya, P. & Romano-Mazzotti, L. Health economic assessment of universal immunization of toddlers against hepatitis A virus (HAV) in Mexico. Hum. Vaccin. Immunother. 12, 52\u201363 (2016).","journal-title":"Hum. Vaccin. Immunother."},{"key":"461_CR187","doi-asserted-by":"publisher","first-page":"A227","DOI":"10.1016\/j.vaccine.2014.12.077","volume":"33","author":"C Vizzotti","year":"2015","unstructured":"Vizzotti, C. et al. Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina. Vaccine 33, A227\u2013232 (2015).","journal-title":"Vaccine"},{"key":"461_CR188","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1016\/j.vaccine.2012.07.049","volume":"30","author":"J Luyten","year":"2012","unstructured":"Luyten, J., Van de Sande, S., de Schrijver, K., Van Damme, P. & Beutels, P. Cost-effectiveness of hepatitis A vaccination for adults in Belgium. Vaccine 30, 6070\u20136080 (2012).","journal-title":"Vaccine"},{"key":"461_CR189","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2165\/00019053-200119030-00006","volume":"19","author":"G Chodick","year":"2001","unstructured":"Chodick, G., Lerman, Y., Peled, T., Aloni, H. & Ashkenazi, S. Cost-benefit analysis of active vaccination campaigns against hepatitis A among daycare centre personnel in Israel. Pharmacoeconomics 19, 281\u2013291 (2001).","journal-title":"Pharmacoeconomics"},{"key":"461_CR190","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3201\/eid1704.101169","volume":"17","author":"U P\u00e9rez-Sautu","year":"2011","unstructured":"P\u00e9rez-Sautu, U. et al. Hepatitis a virus vaccine escape variants and potential new serotype emergence. Emerg. Infect. Dis. 17, 734\u2013737 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"461_CR191","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ebiom.2018.11.023","volume":"39","author":"A Sabri\u00e0","year":"2019","unstructured":"Sabri\u00e0, A. et al. Evidence for positive selection of hepatitis A virus antigenic variants in vaccinated men-having-sex-with men patients: implications for immunization policies. EBioMedicine 39, 348\u2013357 (2019).","journal-title":"EBioMedicine"},{"key":"461_CR192","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.antiviral.2018.04.007","volume":"154","author":"W Jiang","year":"2018","unstructured":"Jiang, W., Muhammad, F., Ma, P., Liu, X. & Long, G. Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system. Antivir. Res. 154, 51\u201357 (2018).","journal-title":"Antivir. Res."},{"key":"461_CR193","doi-asserted-by":"publisher","DOI":"10.3390\/v13101900","author":"M Migueres","year":"2021","unstructured":"Migueres, M., Lhomme, S. & Izopet, J. Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment. Viruses https:\/\/doi.org\/10.3390\/v13101900 (2021).","journal-title":"Viruses"},{"key":"461_CR194","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1046\/j.1365-2036.1999.00592.x","volume":"13","author":"P Fabris","year":"1999","unstructured":"Fabris, P. et al. Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study. Aliment. Pharmacol. Ther. 13, 1187\u20131193 (1999).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"461_CR195","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1155\/2006\/624832","volume":"20","author":"MG Swain","year":"2006","unstructured":"Swain, M. G. Fatigue in liver disease: pathophysiology and clinical management. Can. J. Gastroenterol. 20, 181\u2013188 (2006).","journal-title":"Can. J. Gastroenterol."},{"key":"461_CR196","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2893.1995.tb00018.x","volume":"2","author":"GJ Berelowitz","year":"1995","unstructured":"Berelowitz, G. J., Burgess, A. P., Thanabalasingham, T., Murray-Lyon, I. M. & Wright, D. J. Post-hepatitis syndrome revisited. J. Viral Hepat. 2, 133\u2013138 (1995).","journal-title":"J. Viral Hepat."},{"key":"461_CR197","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1128\/CMR.14.1.38-58.2001","volume":"14","author":"JA Cuthbert","year":"2001","unstructured":"Cuthbert, J. A. Hepatitis A: old and new. Clin. Microbiol. Rev. 14, 38\u201358 (2001).","journal-title":"Clin. Microbiol. Rev."},{"key":"461_CR198","volume":"15","author":"MB Alebaji","year":"2023","unstructured":"Alebaji, M. B. et al. Prolonged cholestasis following acute hepatitis A infection: case report and a review of literature. Cureus 15, e38511 (2023).","journal-title":"Cureus"},{"key":"461_CR199","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3389\/fimmu.2019.02490","volume":"10","author":"R Xue","year":"2019","unstructured":"Xue, R. & Meng, Q. The management of glucocorticoid therapy in liver failure. Front. Immunol. 10, 2490 (2019).","journal-title":"Front. Immunol."},{"key":"461_CR200","doi-asserted-by":"publisher","first-page":"omz080","DOI":"10.1093\/omcr\/omz080","volume":"2019","author":"D Daghman","year":"2019","unstructured":"Daghman, D., Rez, M. S., Soltany, A. & Alsaleh, A. Two case reports of corticosteroid administration-prolonged and pulsed therapy-in treatment of pruritus in cholestatic hepatitis A patients. Oxf. Med. Case Rep. 2019, omz080 (2019).","journal-title":"Oxf. Med. Case Rep."},{"issue":"Suppl. 1","key":"461_CR201","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0264-410X(92)90534-Q","volume":"10","author":"ER Schiff","year":"1992","unstructured":"Schiff, E. R. Atypical clinical manifestations of hepatitis A. Vaccine 10 (Suppl. 1), 18\u201320 (1992).","journal-title":"Vaccine"},{"key":"461_CR202","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3350\/kjhep.2010.16.3.329","volume":"16","author":"EL Yoon","year":"2010","unstructured":"Yoon, E. L. et al. Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases. Korean J. Hepatol. 16, 329\u2013333 (2010).","journal-title":"Korean J. Hepatol."},{"key":"461_CR203","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1365-2257.1997.00206.x","volume":"19","author":"JA Tibble","year":"1997","unstructured":"Tibble, J. A., Ireland, A. & Duncan, J. R. Acute auto immune haemolytic anaemia secondary to hepatitis A infection. Clin. Lab. Haematol. 19, 73\u201375 (1997).","journal-title":"Clin. Lab. Haematol."},{"key":"461_CR204","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/hep.21439","volume":"44","author":"RM Taylor","year":"2006","unstructured":"Taylor, R. M. et al. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology 44, 1589\u20131597 (2006).","journal-title":"Hepatology"},{"key":"461_CR205","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","volume":"124","author":"R Wiesner","year":"2003","unstructured":"Wiesner, R. et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124, 91\u201396 (2003).","journal-title":"Gastroenterology"},{"key":"461_CR206","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jhep.2007.01.009","volume":"46","author":"EL Renner","year":"2007","unstructured":"Renner, E. L. How to decide when to list a patient with acute liver failure for liver transplantation? Clichy or King\u2019s College criteria, or something else? J. Hepatol. 46, 554\u2013557 (2007).","journal-title":"J. Hepatol."},{"key":"461_CR207","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000252778","volume":"53","author":"YJ Kim","year":"2010","unstructured":"Kim, Y. J. & Lee, H. S. Increasing incidence of hepatitis A in Korean adults. Intervirology 53, 10\u201314 (2010).","journal-title":"Intervirology"},{"key":"461_CR208","first-page":"1107","volume":"36","author":"SV Bendre","year":"1999","unstructured":"Bendre, S. V. et al. Fulminant hepatic failure: etiology, viral markers and outcome. Indian Pediatr. 36, 1107\u20131112 (1999).","journal-title":"Indian Pediatr."},{"key":"461_CR209","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3350\/kjhep.2010.16.3.295","volume":"16","author":"JI Kim","year":"2010","unstructured":"Kim, J. I. et al. Factors influencing the severity of acute viral hepatitis A. Korean J. Hepatol. 16, 295\u2013300 (2010).","journal-title":"Korean J. Hepatol."},{"key":"461_CR210","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1590\/S1413-86702009000500002","volume":"13","author":"DC Santos","year":"2009","unstructured":"Santos, D. C. et al. Fulminant hepatitis failure in adults and children from a Public Hospital in Rio de Janeiro, Brazil. Braz. J. Infect. Dis. 13, 323\u2013329 (2009).","journal-title":"Braz. J. Infect. Dis."},{"key":"461_CR211","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/INF.0000000000000042","volume":"33","author":"C Vizzotti","year":"2014","unstructured":"Vizzotti, C. et al. Impact of the single-dose immunization strategy against hepatitis A in Argentina. Pediatr. Infect. Dis. J. 33, 84\u201388 (2014).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"461_CR212","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.psychres.2017.12.037","volume":"261","author":"SD Gale","year":"2018","unstructured":"Gale, S. D., Berrett, A. N., Erickson, L. D., Brown, B. L. & Hedges, D. W. Association between virus exposure and depression in US adults. Psychiatry Res. 261, 73\u201379 (2018).","journal-title":"Psychiatry Res."},{"issue":"Suppl. 1","key":"461_CR213","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0264-410X(92)90550-4","volume":"10","author":"CH Hoke Jr","year":"1992","unstructured":"Hoke, C. H. Jr. et al. Hepatitis A in the US Army: epidemiology and vaccine development. Vaccine 10 (Suppl. 1), 75\u201379 (1992).","journal-title":"Vaccine"},{"key":"461_CR214","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1016\/S0264-410X(00)00091-8","volume":"18","author":"D Gillis","year":"2000","unstructured":"Gillis, D. et al. Active versus passive immunization against hepatitis A in the Israel defence forces: a cost-benefit analysis. Vaccine 18, 3005\u20133010 (2000).","journal-title":"Vaccine"},{"key":"461_CR215","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S0950268817002837","volume":"146","author":"CG Teo","year":"2018","unstructured":"Teo, C. G. 19th-century and early 20th-century jaundice outbreaks, the USA. Epidemiol. Infect. 146, 138\u2013146 (2018).","journal-title":"Epidemiol. Infect."},{"key":"461_CR216","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13476","volume":"23","author":"MED Navarro","year":"2021","unstructured":"Navarro, M. E. D. et al. Liver transplant evaluation for fulminant liver failure due to acute hepatitis A infection: case series and literature review. Transpl. Infect. Dis. 23, e13476 (2021).","journal-title":"Transpl. Infect. Dis."},{"key":"461_CR217","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/liv.12553","volume":"34","author":"LS Yang","year":"2014","unstructured":"Yang, L. S., Shan, L. L., Saxena, A. & Morris, D. L. Liver transplantation: a systematic review of long-term quality of life. Liver Int. 34, 1298\u20131313 (2014).","journal-title":"Liver Int."},{"key":"461_CR218","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cld.2022.03.010","volume":"26","author":"SK Smith","year":"2022","unstructured":"Smith, S. K. & Miloh, T. Pediatric liver transplantation. Clin. Liver Dis. 26, 521\u2013535 (2022).","journal-title":"Clin. Liver Dis."},{"key":"461_CR219","doi-asserted-by":"publisher","first-page":"101468","DOI":"10.1016\/j.trim.2021.101468","volume":"69","author":"B Demir","year":"2021","unstructured":"Demir, B. & Bulbuloglu, S. The effect of immunosuppression therapy on activities of daily living and comfort level after liver transplantation. Transpl. Immunol. 69, 101468 (2021).","journal-title":"Transpl. Immunol."},{"key":"461_CR220","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/lt.25742","volume":"26","author":"MA Dunn","year":"2020","unstructured":"Dunn, M. A., Rogal, S. S., Duarte-Rojo, A. & Lai, J. C. Physical function, physical activity, and quality of life after liver transplantation. Liver Transpl. 26, 702\u2013708 (2020).","journal-title":"Liver Transpl."},{"key":"461_CR221","first-page":"CD013204","volume":"5","author":"\u00c8 P\u00e9rez-Amate","year":"2023","unstructured":"P\u00e9rez-Amate, \u00c8., Roqu\u00e9-Figuls, M., Fern\u00e1ndez-Gonz\u00e1lez, M. & Gin\u00e9-Garriga, M. Exercise interventions for adults after liver transplantation. Cochrane Database Syst. Rev. 5, CD013204 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"461_CR222","doi-asserted-by":"publisher","first-page":"101684","DOI":"10.1016\/j.bpg.2020.101684","volume":"46\u201347","author":"F \u00c5berg","year":"2020","unstructured":"\u00c5berg, F. Quality of life after liver transplantation. Best Pract. Res. Clin. Gastroenterol. 46\u201347, 101684 (2020).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"461_CR223","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/00223891.2019.1694527","volume":"102","author":"DM Nghiem","year":"2020","unstructured":"Nghiem, D. M., Gomez, J., Gloston, G. F., Torres, D. S. & Marek, R. J. Psychological assessment instruments for use in liver and kidney transplant evaluations: scarcity of evidence and recommendations. J. Pers. Assess. 102, 183\u2013195 (2020).","journal-title":"J. Pers. Assess."},{"key":"461_CR224","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/MCO.0000000000000491","volume":"21","author":"LR Anast\u00e1cio","year":"2018","unstructured":"Anast\u00e1cio, L. R. & Ferreira, S. C. Nutrition, dietary intake, and eating behavior after liver transplantation. Curr. Opin. Clin. Nutr. Metab. Care 21, 381\u2013387 (2018).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"461_CR225","unstructured":"World Health Organization. Global Health Sector Strategy on Viral Hepatitis 2016-2021: Towards Ending Viral Hepatitis. WHO https:\/\/apps.who.int\/iris\/handle\/10665\/246177 (2016)."},{"key":"461_CR226","unstructured":"World Health Organization. Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022-2030. WHO https:\/\/www.who.int\/publications\/i\/item\/9789240053779 (2022)."},{"issue":"Suppl. 1","key":"461_CR227","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0264-410X(92)90568-5","volume":"10","author":"MH Sjogren","year":"1992","unstructured":"Sjogren, M. H. et al. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate. Vaccine 10 (Suppl. 1), 135\u2013137 (1992).","journal-title":"Vaccine"},{"key":"461_CR228","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1016\/j.vaccine.2009.05.034","volume":"27","author":"A Kaltenb\u00f6ck","year":"2009","unstructured":"Kaltenb\u00f6ck, A. et al. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: a single-blind, randomized, controlled phase 3 study. Vaccine 27, 4483\u20134489 (2009).","journal-title":"Vaccine"},{"key":"461_CR229","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.vaccine.2006.11.001","volume":"25","author":"C Dong","year":"2007","unstructured":"Dong, C., Dai, X. & Meng, J. H. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E. Vaccine 25, 1662\u20131668 (2007).","journal-title":"Vaccine"},{"key":"461_CR230","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/jmv.1890400115","volume":"40","author":"BH Robertson","year":"1993","unstructured":"Robertson, B. H. et al. Antibody response to nonstructural proteins of hepatitis A virus following infection. J. Med. Virol. 40, 76\u201382 (1993).","journal-title":"J. Med. Virol."},{"key":"461_CR231","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/S0264-410X(00)00560-0","volume":"19","author":"Y Kabrane-Lazizi","year":"2001","unstructured":"Kabrane-Lazizi, Y., Emerson, S. U., Herzog, C. & Purcell, R. H. Detection of antibodies to HAV 3C proteinase in experimentally infected chimpanzees and in naturally infected children. Vaccine 19, 2878\u20132883 (2001).","journal-title":"Vaccine"},{"key":"461_CR232","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1016\/j.vaccine.2017.08.089","volume":"35","author":"K Bohm","year":"2017","unstructured":"Bohm, K., Filomena, A., Schneiderhan-Marra, N., Krause, G. & Sievers, C. Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology. Vaccine 35, 5883\u20135889 (2017).","journal-title":"Vaccine"},{"key":"461_CR233","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1097\/INF.0000000000001640","volume":"36","author":"R Bassal","year":"2017","unstructured":"Bassal, R. et al. Seroprevalence of hepatitis A twelve years after the implementation of Toddlers\u2019 Vaccination: a population-based study in Israel. Pediatr. Infect. Dis. J. 36, e248\u2013e251 (2017).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"461_CR234","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/jvh.13074","volume":"26","author":"V Arankalle","year":"2019","unstructured":"Arankalle, V. et al. Age-stratified anti-HAV positivity in Pune, India after two decades: has voluntary vaccination impacted overall exposure to HAV? J. Viral Hepat. 26, 757\u2013760 (2019).","journal-title":"J. Viral Hepat."},{"key":"461_CR235","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1016\/j.vaccine.2017.08.022","volume":"35","author":"D Jayasundara","year":"2017","unstructured":"Jayasundara, D. et al. Quantifying the population effects of vaccination and migration on hepatitis A seroepidemiology in Australia. Vaccine 35, 5228\u20135234 (2017).","journal-title":"Vaccine"},{"key":"461_CR236","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1128\/JVI.75.8.3841-3850.2001","volume":"75","author":"NL Teterina","year":"2001","unstructured":"Teterina, N. L. et al. Requirements for assembly of poliovirus replication complexes and negative-strand RNA synthesis. J. Virol. 75, 3841\u20133850 (2001).","journal-title":"J. Virol."},{"key":"461_CR237","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1073\/pnas.82.7.2143","volume":"82","author":"BM Baroudy","year":"1985","unstructured":"Baroudy, B. M. et al. Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase. Proc. Natl Acad. Sci. USA 82, 2143\u20132147 (1985).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"461_CR238","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1099\/0022-1317-74-4-677","volume":"74","author":"D Jurgensen","year":"1993","unstructured":"Jurgensen, D., Kusov, Y. Y., Facke, M., Krausslich, H. G. & Gauss-Muller, V. Cell-free translation and proteolytic processing of the hepatitis A virus polyprotein. J. Gen. Virol. 74, 677\u2013683 (1993).","journal-title":"J. Gen. Virol."},{"key":"461_CR239","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1128\/jvi.69.3.1727-1733.1995","volume":"69","author":"T Schultheiss","year":"1995","unstructured":"Schultheiss, T., Sommergruber, W., Kusov, Y. & Gauss-Muller, V. Cleavage specificity of purified recombinant hepatitis A virus 3C proteinase on natural substrates. J. Virol. 69, 1727\u20131733 (1995).","journal-title":"J. Virol."},{"key":"461_CR240","doi-asserted-by":"publisher","first-page":"8013","DOI":"10.1128\/JVI.72.10.8013-8020.1998","volume":"72","author":"C Probst","year":"1998","unstructured":"Probst, C., Jecht, M. & Gauss-Muller, V. Processing of proteinase precursors and their effect on hepatitis A virus particle formation. J. Virol. 72, 8013\u20138020 (1998).","journal-title":"J. Virol."},{"key":"461_CR241","unstructured":"ISO. ISO 15216-1:2017. Microbiology of the Food Chain \u2014 Horizontal Method for Determination of Hepatitis A Virus and Norovirus Using Real-time RT-PCR \u2014 Part 1: Method for Quantification. ISO https:\/\/www.iso.org\/standard\/65681.html (2017)."},{"key":"461_CR242","unstructured":"ISO. ISO 15216-2:2019. Microbiology of the Food Chain \u2014 Horizontal Method for Determination of Hepatitis A virus and Norovirus Using Real-time RT-PCR \u2014 Part 2: Method for Detection. ISO https:\/\/www.iso.org\/standard\/74263.html (2019)."},{"key":"461_CR243","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3389\/fmicb.2020.00874","volume":"11","author":"FM Batista","year":"2020","unstructured":"Batista, F. M. et al. Whole genome sequencing of hepatitis A virus using a PCR-free single-molecule nanopore sequencing approach. Front. Microbiol. 11, 874 (2020).","journal-title":"Front. Microbiol."},{"key":"461_CR244","first-page":"1","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","unstructured":"Centers for Disease Control and Prevention et al. Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm. Rep. 53, 1\u201333 (2004).","journal-title":"MMWR Recomm. Rep."}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00461-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00461-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00461-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T08:05:25Z","timestamp":1695888325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00461-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":244,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1038\/s41572-023-00461-2","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"23 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}